<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>DSpace Community: School of Population Health &amp; Clinical Practice</title>
    <link>http://hdl.handle.net/2440/13901</link>
    <description />
    <textInput>
      <title>The Community's search engine</title>
      <description>Search the Channel</description>
      <name>search</name>
      <link>http://digital.library.adelaide.edu.au/dspace/simple-search</link>
    </textInput>
    <item>
      <title>Exploring trends in laryngeal cancer incidence, mortality and survival: implications for research and cancer control</title>
      <link>http://hdl.handle.net/2440/53747</link>
      <description>Title: Exploring trends in laryngeal cancer incidence, mortality and survival: implications for research and cancer control
&lt;br/&gt;
&lt;br/&gt;Author: Luke, Colin G.; Yeoh, Eric; Roder, David Murray
&lt;br/&gt;
&lt;br/&gt;Abstract: South Australian registry data were used to investigate trends in laryngeal cancer age-standardised incidence, mortality and disease-specific survival from 1977 to 2005</description>
      <pubDate>Mon, 29 Oct 2007 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Vitamin D and people with intellectual disability</title>
      <link>http://hdl.handle.net/2440/53746</link>
      <description>Title: Vitamin D and people with intellectual disability
&lt;br/&gt;
&lt;br/&gt;Author: Vanlint, Simon John; Nugent, Michael William E.; Durvasula, Seeta
&lt;br/&gt;
&lt;br/&gt;Abstract: BACKGROUND: Vitamin D is essential for the normal functioning of a diverse range of metabolic processes, especially bone health. It is widely appreciated that the elderly are at increased risk of vitamin D insufficiency, but it is less well known that people with intellectual disability are also at increased risk.

OBJECTIVE: This article summarises the issues regarding vitamin D in people with intellectual disability, making recommendations about screening, management and follow up.

DISCUSSION: The prevalence of intellectual disability in the Australian population has been estimated at just over 1%, implying that most general practitioners will care for several people with intellectual disability. Relatively simple steps are likely to have a significant impact on the health of this vulnerable group of people.</description>
      <pubDate>Mon, 29 Oct 2007 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Preventing relapse of depression in primary care: a pilot study of the "Keeping the blues away" program</title>
      <link>http://hdl.handle.net/2440/53745</link>
      <description>Title: Preventing relapse of depression in primary care: a pilot study of the "Keeping the blues away" program
&lt;br/&gt;
&lt;br/&gt;Author: Howell, Catherine Adele; Turnbull, Deborah Anne; Beilby, Justin John; Marshall, Charlotte Ann; Briggs, Nancy Elizabeth; Newbury, Wendy Lynne
&lt;br/&gt;
&lt;br/&gt;Abstract: Objectives: To determine the effectiveness of “Keeping the blues away” (KBA), a manualised depression relapse prevention program for general practice, in reducing the relapse of depression compared with usual care (with the aim of halving the relapse rate), and in reducing depression severity and improving the process of care.

Design and setting: A cluster randomised controlled trial conducted in 2004–2005  in South Australian general practices.

Participants: 43 general practitioners from 23 urban and rural practices recruited 110 patients with depression (age range, 18–75 years).

Intervention: GP training manual or patient manual and relaxation CD; 20 hours of training on depression, the study protocol, assessment tools and skills.

Main outcome measures: Relative risk (RR) of depression relapse; depression severity and quality of life scores.

Results: There were no significant differences in relapse rates between the groups (χ21 = 1.51; P = 0.23), although there was a non-significant tendency for relapse to be reduced in the KBA group (RR = 0.77; 95% CI, 0.50–2.05). Older patients (≥ 50 years) in the KBA group showed a significantly lower probability of relapse than those in the control group (P = 0.018). There was a decrease in depression scores in both groups. KBA participants had more severe depression at baseline, and the reduction in severity in those with symptoms for &amp;gt;6 months was nearly significant (P = 0.06). KBA was positively received by GPs and patients.

Conclusions: Although this pilot study of a small sample did not achieve its primary outcome of reducing depression relapse by 50%, KBA was found to be a promising program for older patients and for those with more severe or persistent symptoms.</description>
      <pubDate>Mon, 29 Oct 2007 22:58:59 GMT</pubDate>
    </item>
    <item>
      <title>Do advertisements in clinical software influence prescribing?</title>
      <link>http://hdl.handle.net/2440/53744</link>
      <description>Title: Do advertisements in clinical software influence prescribing?
&lt;br/&gt;
&lt;br/&gt;Author: Mansfield, Peter Richard</description>
      <pubDate>Mon, 29 Oct 2007 22:58:59 GMT</pubDate>
    </item>
  </channel>
</rss>

